{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:45:41Z","timestamp":1788281141813,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1053\/j.jrn.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T16:51:59Z","timestamp":1402419119000},"page":"261-267","source":"Crossref","is-referenced-by-count":51,"title":["Long-Term Safety and Efficacy of a Novel Iron-Containing Phosphate Binder, JTT-751, in Patients Receiving Hemodialysis"],"prefix":"10.1053","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-592X","authenticated-orcid":false,"given":"Keitaro","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hirakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2014.03.006_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2014.03.006_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2014.03.006_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"5 Suppl","key":"10.1053\/j.jrn.2014.03.006_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0272-6386(03)00372-X","article-title":"Cardiovascular complications in chronic kidney disease","volume":"41","author":"Sarnak","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2014.03.006_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"Fukagawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.jrn.2014.03.006_bib6","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2014.03.006_bib7","first-page":"43","article-title":"Phosphate binders in CKD: past, present, and future","volume":"10","author":"Nagina","year":"2009","journal-title":"J Indian Acad Clin Med"},{"key":"10.1053\/j.jrn.2014.03.006_bib8","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000341922","article-title":"The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients","volume":"121","author":"Sinsakul","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2014.03.006_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000348805","article-title":"Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification","volume":"37","author":"Iida","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2014.03.006_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000344008","article-title":"Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Yokoyama","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2014.03.006_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jcp.32.1.56","article-title":"Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual","volume":"32","author":"Payne","year":"1979","journal-title":"J Clin Pathol"},{"issue":"Suppl 3","key":"10.1053\/j.jrn.2014.03.006_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ndt\/16.suppl_3.22","article-title":"Practical guidelines for the use of NESP in treating renal anaemia","volume":"16","author":"Aljima","year":"2001","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2014.03.006_bib13","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1093\/ndt\/gfq305","article-title":"Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial","volume":"25","author":"Carrera","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2014.03.006_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/2230-8210.93739","article-title":"Erythropoietin use and abuse","volume":"16","author":"John","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1053\/j.jrn.2014.03.006_bib15","article-title":"A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis","author":"Yokoyama","year":"2013","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2014.03.006_bib16","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2014.03.006_bib17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","article-title":"Determinants of progressive vascular calcification in hemodialysis patients","volume":"19","author":"Chertow","year":"2004","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2014.03.006_bib18","doi-asserted-by":"crossref","first-page":"c15","DOI":"10.1159\/000149239","article-title":"long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment","volume":"110","author":"Hutchison","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2014.03.006_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajh.20056","article-title":"Parenteral iron therapy options","volume":"76","author":"Silverstein","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1053\/j.jrn.2014.03.006_bib20","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/ndt\/gft062","article-title":"Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"28","author":"Bailie","year":"2013","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2014.03.006_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOH.0b013e3282f73335","article-title":"Iron regulation and erythropoiesis","volume":"15","author":"Nemeth","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.jrn.2014.03.006_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3324\/haematol.11705","article-title":"Hepcidin: from discovery to differential diagnosis","volume":"93","author":"Kemna","year":"2008","journal-title":"Haetmatologica"},{"key":"10.1053\/j.jrn.2014.03.006_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2014.03.006_bib24","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1093\/ndt\/14.11.2680","article-title":"Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy","volume":"14","author":"Lim","year":"1999","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2014.03.006_bib25","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.clinbiochem.2008.07.007","article-title":"Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study","volume":"41","author":"Anraku","year":"2008","journal-title":"Clin Biochem"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227614000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227614000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T09:30:27Z","timestamp":1538559027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227614000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1051227614000545"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2014.03.006","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}